
ISSN No. 2321-2705 | DOI: 10.51244/IJRSIVolume XII Issue XV October 2025 | Special Issue on Public Health
Page 2628
www.rsisinternational.org



















Background: The most common malignancy and leading cancer-related death in women globally is breast
cancer, including Sub-Saharan Africa. Over 60% of Nigerian patients present late due to lack of awareness and
utilization of mammography screening. This study assessed prediagnosis awareness and practice of
mammography screening in breast cancer patients at the MEDSERVE-LUTH Cancer Centre.
Methods: A cross-sectional descriptive study was conducted among 196 breast cancer patients at the
MEDSERVE-LUTH Cancer Centre. Structured questionnaires for socio-demographic factors, awareness about
mammography, knowledge and practice of BSE, and health-seeking attitudes were employed for data collection.
Data analysis was done using SPSS v27, and descriptive statistics was employed.
Results: Participant's mean age was 43.6 ± 10.2 years. Mammography screening awareness before diagnosis
was known to only 10.1%, the most common sources being family/friends (3.5%) and social media (4%). Only
2% had undergone mammography before diagnosis, whereas most patients (93.4%) knew BSE. The most
common source of discovering the breast lumps was by BSE in 66.2% of patients, and only 8.1% by
mammography. Cultural and religious opinions (7.1%), expense (1.5%), and distance (1%) were some of the
barriers to the use of mammography. Despite low awareness, 89.4% believed it would have made detection
possible earlier, and 97.5% expressed a willingness to persuade others to undergo screening.
Conclusion: Awareness and use of mammography among Nigerian breast cancer patients remain very low,
despite the major usage of breast self-examination as the first and only method of detection. There is a need for
intervention involving health education, utilization of health professionals, cost control, and increased access to
mammography to enhance earlier diagnosis and survival.
 Breast cancer, Mammography, Awareness, Prediagnosis, Early detection, Nigeria

Breast cancer is the most frequently diagnosed cancer and a primary cause of cancer-related fatalities among
women globally, with its impact growing rapidly in sub-Saharan Africa (SSA), where patients often present with
more advanced stages of the disease and have worse survival rates compared to high-income regions (1,2). More
than a million women are diagnosed with breast cancer each year, leading to approximately 410,000 deaths from
the disease (3–5). Some research indicates that breast cancer is the most significant cause of cancer-related deaths

ISSN No. 2321-2705 | DOI: 10.51244/IJRSIVolume XII Issue XV October 2025 | Special Issue on Public Health
Page 2629
www.rsisinternational.org
among women in Nigeria (6). The rising incidence of breast cancer in developing nations is attributed to
increased life expectancy, urbanization, and the adoption of Western lifestyle habits (4). There exists
considerable variation in breast cancer incidence rates across regions, ranging from 19.3 per 100,000 women in
Eastern Africa to 89.7 per 100,000 women in Eastern Europe (4). The late diagnosis and high mortality rates in
SSA are partly due to inadequate early detection systems, limited access to screening services for the population,
and a lack of awareness regarding screening options like mammography (1,7).
Mammography is the recognized imaging technique for breast cancer screening and has been linked to earlier
diagnoses and decreased mortality where organized screening programs are in place. Nonetheless, in many low-
and middle-income countries (LMICs), including Nigeria, organized mammography initiatives are few, and the
uptake of opportunistic mammography is low due to various obstacles such as lack of awareness, cost, limited
equipment availability, shortage of trained staff, and sociocultural factors hindering participation (7,8). Research
conducted in Nigeria and other SSA locations consistently identifies a lack of awareness about mammography
as a significant barrier, even if geographic access is available, highlighting a crucial gap between availability
and utilization (9).
Crucially, the awareness and previous use of mammography among women ultimately diagnosed with breast
cancerwho could have benefited from earlier screeningsremains low in several hospital-based studies within
SSA. For instance, hospital groups in Ethiopia and similar regions report extremely low levels of prediagnosis
awareness and past mammography usage among breast cancer patients, indicating missed chances for early
detection within the populations that later present with the disease (10). Furthermore, recent cross-sectional
studies and surveys in Nigeria reveal ongoing deficiencies in knowledge, willingness, and practical obstacles
regarding mammography among women in both community and clinical contexts (8,11).
Gaining insight into the levels of awareness, information sources, and barriers present before diagnosis among
patients attending MEDSERVE-LUTH will aid in identifying missed opportunities for earlier detection and
inform targeted interventions, which may include healthcare provider training, community awareness
campaigns, and policy initiatives to enhance affordable access to screening. Assessments at the population level
suggest that enhancing facility capabilities must be complemented by demand-side initiatives aimed at
improving knowledge and acceptance of screening to facilitate earlier diagnosis and better outcomes.
This study seeks to assess the pre-diagnosis awareness and practice of mammography screening among women
diagnosed with breast cancer at the MEDSERVE-LUTH, explore the sources of information and understanding
about mammography, and identify perceived and structural barriers that hindered prior participation.


The study area was the MEDSERVE-LUTH Cancer Centre, which was established in 2019. The MEDSERVE -
LUTH Cancer Centre was a specialized cancer treatment centre that offered cutting-edge therapies and a modern
approach to cancer care in Africa. Situated within the site of Lagos University Teaching Hospital, it possessed
the largest and most experienced oncology team in Nigeria. The treatment centre was equipped with high-quality
modern technology, such as linear accelerators, brachytherapy machines, and treatment planning systems.
Several treatments were also available at the cancer centre, which included internal and external beam radiation
therapy, chemotherapy, and pharmacy treatments.

A descriptive cross-sectional study was conducted to assess levels of awareness of mammography screening
among breast cancer patients at the MEDSERVE -LUTH Cancer Centre before diagnosis.

The study population was conducted among female breast cancer patients at the Department of Clinical and

ISSN No. 2321-2705 | DOI: 10.51244/IJRSIVolume XII Issue XV October 2025 | Special Issue on Public Health
Page 2630
www.rsisinternational.org
Radiation Oncology in the MEDSERVE-LUTH Cancer Centre.


All patients diagnosed with histologically proven breast cancer.
Patients who gave consent and were willing to participate in the study.
Patients receiving treatment at MEDSERVE-LUTH Cancer Centre.

Male breast cancer patients.
Patients with incomplete medical records regarding their breast cancer diagnosis.

The sample size was determined using Cochrane formula
n = z
2
pq/d
2
Where;
n = Sample size
z = Standard deviation (1.96 for 95% confidence interval)
p = best estimate of the population prevalence (10% = 0.1)
q = 1-p
d = Tolerable error (0.05)
2
1.96
2
x 0.1 x 1 – 0.1 = 138.30
0.05
2
The addition of 40% attrition rate was 55.32 + 138.30
Sample size = 194

A purposive sampling technique was used to select respondents who met the inclusion criteria.

Data were collected with the aid of a structured questionnaire, and information was obtained from the patients.
The study questionnaire was based on the research objectives and contained important information about the
patients, which included socio-economic and demographic characteristics, awareness of mammography
screening. Knowledge and practice of breast self-examination (BSE), diagnosis and treatment seeking behaviors,
family history and risk factors, and lifestyle and hormonal factors.

Prior to data analysis, the data were collected with the aid of the questionnaire and manually entered into

ISSN No. 2321-2705 | DOI: 10.51244/IJRSIVolume XII Issue XV October 2025 | Special Issue on Public Health
Page 2631
www.rsisinternational.org
Microsoft Excel Office. They were imported into Statistical Package for Social Science (SPSS) version 27 for
data analysis. The Kolmogorov–Smirnov test was utilized to check for normally distributed data. Data were
presented in frequency, percentage, mean, and standard deviation (SD).

Ethical approval was obtained from the Lagos University Teaching Hospital (LUTH) Human Ethics Research
Committee. Informed consent was obtained from all the study participants, ensuring they knew the nature of the
study, their rights, and the process involved. Participants had the liberty to take part in and withdraw from the
study at any time without consequences. The privacy and confidentiality of the participants were strictly adhered
to throughout the study and beyond.

The mean age of the breast cancer patients was 43.63 ± 10.19 years. The largest proportion of patients was within
the 30–39 years age group (33.2%), followed by those aged 50–59 years (31.2%) and 40–49 years (24.6%),
while only 3% were within the 60–69 years group. Regarding religion, most patients were Christians (62.1%),
while 36.9% were Muslims and 0.5% practiced traditional religion. Regarding ethnicity, Yoruba patients
constituted the majority (75.8%), followed by Igbo (15.2%), with Hausa (1%) and other ethnic groups (8.1%)
making up the remainder. Regarding occupation, most patients were self-employed or engaged in business
(42.4%), 39.4% were classified under other forms of occupation, 12.6% were civil servants, and 4.5% were
private employees. Educational attainment showed that 46% had secondary education, 36.9% had tertiary
education, 13.6% had primary education, and 3% had no formal education. Considering the duration of
diagnosis, 68.4% of patients had been diagnosed for less than six months, 24.8% between 7 months and one
year, while 5.5% had lived with the diagnosis for more than one year.
Table 1: Socio-economic and Demographic Characteristics of BC Patients
Variables
Frequency
Percentage
Age (43.63 ± 10.19)
20 – 29 years
15
7.5
30 – 39 years
66
33.2
40 – 49 years
49
24.6
50 – 59 years
62
31.2
60 – 69 years
6
3
Religion
Christianity
123
62.1
Islam
73
36.9
Traditional worshipper
1
0.5
Ethnicity
Yoruba
150
75.8
Igbo
30
15.2
Hausa
2
1
Others
16
8.1
Occupation
Civil Servant
25
12.6

ISSN No. 2321-2705 | DOI: 10.51244/IJRSIVolume XII Issue XV October 2025 | Special Issue on Public Health
Page 2632
www.rsisinternational.org
Private Employees
9
4.5
Self-employed/Business
84
42.4
Others
78
39.4
Education Level
None
6
3
Primary
27
13.6
Secondary
91
46
Tertiary
73
36.9
Duration of diagnosis
< 6 months
136
68.4
7 months – 1 year
49
24.8
More than 1 year
11
5.5
Only a small proportion of breast cancer patients reported awareness and practice of mammography screening
before diagnosis, with 20 patients (10.1%) indicating awareness, while the majority (88.9%) had no prior
knowledge. Among those who were aware, the most common sources of information were social media (4%),
followed by family and friends (3.5%) and mass media (2%). Despite this awareness, only 4 patients (2%) had
undergone mammography screening, while 17 patients (8.6%) did not, citing religious and cultural beliefs
(7.1%), cost (1.5%), distance (1%), and other reasons (1%). Of those who had screening, only 1 patient (0.5%)
reported doing so one year before diagnosis. Knowledge regarding mammography guidelines was also very low,
as only 2 patients (1%) knew the recommended age for screening, with both incorrectly identifying it as 20 years.
Furthermore, none of the patients knew how often mammography screening should be carried out, as all
respondents (11.1%) reported no knowledge.
Table 2: Awareness and Practice of Mammography Screening of BC Patients
Variables
Frequency
Awareness of mammography screening before diagnosis
Yes
20
No
176
If yes, source of awareness
Family/Friends
7
Mass media
4
Social media
8
Mammography screening after awareness
Yes
4
No
17
If no, reasons for not undergoing mammography screening
Cost
3
Distance
2
Religious/Cultural beliefs
14
Others
2
If yes, how many years before diagnosis did you undergo mammography
screening?
1 year
1

ISSN No. 2321-2705 | DOI: 10.51244/IJRSIVolume XII Issue XV October 2025 | Special Issue on Public Health
Page 2633
www.rsisinternational.org
Do you know at what age a woman should start mammography screening?
Yes
2
No
20
If yes, at what age?
20 yes
2
Do you know how often a woman should undergo mammography screening?
Yes
0
No
22
The majority of breast cancer patients (93.4%) reported knowledge of breast self-examination (BSE), while only
6.6% had no prior awareness. Among those who were aware, the most common source of information was social
media (35.4%), followed by hospitals (26.8%), family and friends (12.1%), and religious gatherings (12.1%).
Mass media accounted for 6.1% as a source of awareness.
Knowledge and Practice of Breast Self-Examination (BSE) of BC Patients
Variables
Frequency
Percentage
Do you know about breast self-examination?
Yes
185
93.4
No
13
6.6
If yes, what are your source of awareness?
Family/Friends
24
12.1
Mass media
12
6.1
Religious gathering
24
12.1
Hospital
53
26.8
Social media
70
35.4
Most patients (66.2%) discovered their breast mass through breast self-examination, while 33.8% did not. In
addition, 41.4% reported that a relative observed the mass. Clinical detection methods were less common, with
14% identifying the mass through ultrasound scan and 8.1% through mammography. Regarding initial
symptoms, the most frequently reported abnormality was a breast lump (57.6%), followed by ulceration or
wound (51%), skin changes (35.9%), breast pain (26.8%), swelling in the armpit (24.7%), and nipple discharge
(11.6%). In terms of health-seeking behavior, the vast majority of patients (89.4%) consulted a doctor within a
few months of noticing abnormal breast changes, while only 9.1% presented within a few weeks, and 1.5%
delayed for a few years. Most patients (89.4%) believed regular mammography screening could have facilitated
earlier detection, and almost all (97.5%) indicated they would encourage other women to undergo regular
mammography screening for early detection of breast cancer. Regarding treatment history, 12.6% of patients had
undergone previous surgery, 94.4% had received radiotherapy, and 98.5% had received chemotherapy. Targeted
therapy had been administered to 39.4% of patients, immunotherapy to 14.1%, and hormonal therapy to 12.1%.
Table 4: Diagnosis and Treatment Seeking Behaviors of BC Patients
Variables
Frequency
Percentage
How do you discover your breast mass?
Breast Self-examination
Yes
131
66.2

ISSN No. 2321-2705 | DOI: 10.51244/IJRSIVolume XII Issue XV October 2025 | Special Issue on Public Health
Page 2634
www.rsisinternational.org
No
67
33.8
Observed by a relative
Yes
82
41.4
No
116
58.6
USS Scan
Yes
28
14.
No
170
85.9
Mammography
Yes
16
8.1
No
182
91.9
What did you first observe?
Lump
Yes
114
57.6
No
84
42.4
Skin changes
Yes
71
35.9
No
127
64.1
Nipple discharge
Yes
23
11.6
No
175
88.4
Pains in the breast
Yes
53
26.8
No
145
73.2
Ulceration/Wound
Yes
101
51
No
96
48.5
Swelling in the armpit
Yes
49
24.7
No
149
75.3
How soon did you see a doctor after noticing an abnormal breast change?
Within a few weeks
18
9.1
Within a few months
177
89.4
After a few years
3
1.5
Do you believe regular mammography screening could have helped detect your
breast cancer earlier?
Yes
177
89.4
No
10
5.1

ISSN No. 2321-2705 | DOI: 10.51244/IJRSIVolume XII Issue XV October 2025 | Special Issue on Public Health
Page 2635
www.rsisinternational.org
Not sure
11
5.6
Would you encourage other women to undergo regular mammography screening
for early detection of breast cancer?
Yes
193
97.5
No
3
1.5
Not sure
1
0.5
Have you done surgery previously?
Yes
25
12.6
No
172
86.9
Have you received radiotherapy previously?
Yes
187
94.4
No
10
5.1
Have you received chemotherapy previously?
Yes
195
98.5
No
3
1.5
Have you received targeted therapy previously?
Yes
78
39.4
No
120
60.6
Have you received immunotherapy previously?
Yes
28
14.1
No
170
85.9
Have you received hormonal therapy previously?
Yes
24
12.1
No
174
87.9
Most patients (91.9%) were aware that breast cancer could be hereditary, while 7.6% did not know. A positive
family history of cancer was reported in 67.7% of patients, with affected relatives including mothers (25.3%),
aunts (21.7%), and sisters (19.7%). Regarding reproductive history, the age of menarche was most commonly
13 years (44.9%), followed by 12 years (30.8%) and 14 years (19.7%), while very few experienced menarche at
11, 15, or 16 years. The majority of patients (96%) had children, with the age at first childbirth most frequently
between 21–25 years (49.6%), followed by 26–30 years (32.4%) and 16–20 years (12.6%). Most patients
(65.7%) had between 3 and 4 children, while 15.1% each had 1–2 children or 5–6 children. Breastfeeding
practices were also common, as 94.9% of patients reported breastfeeding their children. Among them, the
majority breastfed for 7 months to 1 year (65.1%), followed by 1–2 years (29.3%), while only 0.5% breastfed
for less than 6 months.
Table 5: Family history and Risk factors of BC Patients
Variables
Frequency
Percentage
Do you know that breast cancer can be hereditary?
Yes
182
91.9
No
15
7.6

ISSN No. 2321-2705 | DOI: 10.51244/IJRSIVolume XII Issue XV October 2025 | Special Issue on Public Health
Page 2636
www.rsisinternational.org
Family history of cancer
Yes
134
67.7
No
64
32.3
If yes, relationship to the affected relative
Aunt
43
21.7
Mother
50
25.3
Sister
39
19.7
Others
1
0.5
Age of first menstrual period
11 years
4
2
12 years
61
30.8
13 years
89
44.9
14 years
39
19.7
15 years
4
2
16 years
1
0.5
Do you have children?
Yes
190
96
No
8
4
If yes, age of your first child
16 – 20 years
25
12.6
21 – 25 years
98
49.6
26 – 30 years
64
32.4
31 years and above
4
2
How many children do you have?
1 – 2
30
15.1
3 – 4
130
65.7
5 – 6
30
15.1
Do you breastfeed your children?
Yes
188
94.9
No
2
1
If yes, for how long did you breastfeed?
0 - 6 months
1
0.5
7 months – 1 year
129
65.1
1 - 2 years
58
29.3
More than half of the patients (57.1%) reported a history of oral contraceptive use, while 42.9% had never used
them. Among those who had used oral contraceptives, the majority (47.9%) reported use for more than one year,
while smaller proportions used them for less than six months (4.5%) or between seven months and one year
(4.5%). With respect to menopausal status, 33.8% of patients had stopped menstruating, whereas 65.7% were

ISSN No. 2321-2705 | DOI: 10.51244/IJRSIVolume XII Issue XV October 2025 | Special Issue on Public Health
Page 2637
www.rsisinternational.org
still menstruating. Among those who had reached menopause, 13.1% reported cessation before the age of 50
years, while 19.7% stopped menstruating after 50 years.
Table 6: Lifestyle and Hormonal factors of BC Patients
Variables
Frequency
Percentage
Have you used oral contraceptives?
Yes
113
57.1
No
85
42.9
If yes, for how many years did you use oral contraceptives?
< 6 months
9
4.5
7 months - 1 year
9
4.5
More than 1 year
95
47.9
Have you stopped menstruating?
Yes
67
33.8
No
130
65.7
If yes, at what age did you stop?
< 50 years
26
13.1
> 50 years
39
19.7

This study highlights with concern the extremely low prediagnosis awareness and mammography uptake among
breast cancer patients in the Lagos University Teaching Hospital. Fewer than a limited percentage of patients
were aware of mammography, and fewer still had ever undergone screening before diagnosis, the results
mirroring historic patterns in Nigeria and across sub-Saharan Africa (SSA) of late diagnosis of breast cancer and
poor survival (2,11). The ability of these findings to remain robust after decades of campaign activity underscores
system-wide weaknesses that go beyond practice at the individual level and require structural health system
reform.
Our findings concur with several Nigerian studies that have reported mammography awareness and practice rates
of 10–25% among hospital and community women (1,8,12). Another study in Ibadan showed that only 12% of
women had ever heard of mammography, and fewer than 5% had been screened before diagnosis (9). In a
systematic review of existing literature in Sub-Saharan Africa, Omisore et al. (7) indicated that generally,
awareness of mammography is low, and the rate of screening never exceeds 10%, except in specific pilot projects
or research studies. In contrast, structured screening programs in developed countries have over 60% uptake,
resulting in earlier detection and significantly improved survival rates (8). These disparities indicate variations
in access to diagnostic resources, health education, and systemic support for cancer prevention.
The finding in our study was that most participants who were aware of mammography had learned it from mass
media, social networks, or social media websites, but not from health care providers. Such a pattern has already
been recorded in Nigeria, where doctors and nurses are barely cited as sources of first-hand information on breast
cancer screening (2,13). Conversely, in high-resource countries, healthcare providers are the most authoritative
and efficient supporters of uptake of screening (14,15). This suggests a missed opportunity for Nigerian
healthcare providers, especially primary care providers, to integrate cancer education into routine patient care.
Nearly two-thirds of patients in this research had BSE noted as the means by which they identified their breast
lump. While BSE has been highly promoted throughout Nigeria because of its ease and low cost, evidence
suggests that it is not a suitable substitute for mammography or clinical breast examination (CBE) for early
detection and survival rates (16,17). Prioritization of BSE in health campaigns without concurrent investment in
mammography can inadvertently promote late detection because women will report only upon discovering
palpable lumps that typically indicate advanced disease.

ISSN No. 2321-2705 | DOI: 10.51244/IJRSIVolume XII Issue XV October 2025 | Special Issue on Public Health
Page 2638
www.rsisinternational.org
The hindrances found in this research were cost, distance to health centers, cultural and religious views, stigma,
and not knowing screening intervals. These are consistent with hindrances reported in other SSA settings (7,13).
For instance, cultural myths regarding cancer as well as fatalistic attitudes in Ethiopia and Ghana were key
discouragements to screening uptake, with cost and geographic hindrances being similarly salient (10,18). In
Nigeria, where out-of-pocket health expenditure prevails, the affordability of mammography is a major challenge
for women of low- and middle-income backgrounds (8,9). Additionally, inequities are further worsened by the
absence of organized national screening programmes, with access for rural women disproportionately limited to
urban tertiary hospitals. Although prediagnosis awareness was low, our study found that most women were
willing to persuade others to have mammography if provided with the chance. This means that acceptability of
screening is not the primary issue, but the issues are awareness, affordability, and accessibility.
This study provides hospital-based data in women later diagnosed with breast cancer, which indicates a different
perspective on prediagnosis knowledge and utilization gaps, and mammography use. The findings from the study
are diminished by having a single-center design and cannot be extrapolated to all of Nigeria, especially rural
areas, where awareness and availability are likely even poorer.

This study showed persistent low prediagnosis awareness and utilization of mammography screening among
breast cancer cases in this region. Even when access to the mammography facility is available, only 10.1% of
the respondents had ever heard of the screening tool, and only 2% had ever been exposed to mammography
before diagnosis. However, breast self-examination was the most widely used lump detection practice, and this
points to the lack of organized, system-level approaches to early breast cancer detection in Nigeria. Health
policy-makers and stakeholders need to focus on incorporating awareness of mammography into primary health
and community programs, subsidize screening expenses, and build health system infrastructure for early
detection. In the absence of such directed interventions, Nigerian women will remain exposed to late presentation
and compromised survival rates of breast cancer.

This study is an original work and is the fruit of various researchers contributing in various capacities.

No funds, grants, or other financial support were received in the preparation of this manuscript.

The authors have no relevant financial or non-financial interests to disclose.

All authors contributed to the study's conception and design. Emmanuel Andero and Samson Ezekiel performed
material preparation, data collection, and analysis. Andero wrote the first draft of the manuscript, and all other
authors commented on previous versions. Everyone read and approved the final manuscript.

1. Anyigba CA, Awandare GA, Paemka L. Breast cancer in sub-Saharan Africa: The current state and
uncertain future. Exp Biol Med (Maywood) [Internet]. 2021 Jun [cited 2025 Oct 3];246(12):1377–87.
Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC8243219/
2. Hailegebireal AH, Bizuayehu HM, Tirore LL. Far behind 90-70-90’s screening target: the prevalence and
determinants of cervical cancer screening among Sub-Saharan African women: evidence from Demographic
and Health Survey. BMC Cancer [Internet]. 2024 Aug 26 [cited 2025 Aug 22];24(1):1050. Available from:
https://doi.org/10.1186/s12885-024-12789-3

ISSN No. 2321-2705 | DOI: 10.51244/IJRSIVolume XII Issue XV October 2025 | Special Issue on Public Health
Page 2639
www.rsisinternational.org
3. Ebubedike UR, Umeh EO, C Anyanwu SN. Mammographic findings of breast cancer screening in patients
with positive family history in South-East Nigeria. Niger J Clin Pract. 2018 Jun;21(6):801–6.
4. Breast cancer [Internet]. [cited 2025 Oct 3]. Available from: https://www.who.int/news-room/fact-
sheets/detail/breast-cancer
5. Tabar L, Yen MF, Vitak B, Chen HHT, Smith RA, Duffy SW. Mammography service screening and
mortality in breast cancer patients: 20-year follow-up before and after introduction of screening. Lancet.
2003 Apr 26;361(9367):1405–10.
6. Amin SM, Ewunonu HAS, Oguntebi E, Liman IM. Breast cancer mortality in a resource-poor country: A
10-year experience in a tertiary institution. Sahel Medical Journal [Internet]. 2017 Sep [cited 2025 Oct 3];
20(3):93. Available from:
https://journals.lww.com/shmj/fulltext/2017/20030/breast_cancer_mortality_in_a_resource_poor.3.aspx
7. Omisore AD, Sutton EJ, Akinola RA, Towoju AG, Akhigbe A, Ebubedike UR, et al. Population-Level
Access to Breast Cancer Early Detection and Diagnosis in Nigeria. JCO Glob Oncol [Internet]. 2023 Dec
[cited 2025 Oct 3];(9):e2300093. Available from: https://ascopubs.org/doi/10.1200/GO.23.00093
8. Olasehinde O, Alatise OI, Arowolo OA, Mango VL, Olajide S OS, Omisore AD, et al. Barriers to
mammography screening in Nigeria: A survey of two communities with different access to screening
facilities. Eur J Cancer Care (Engl) [Internet]. 2019 Mar [cited 2025 Oct 3];28(2):e12986. Available from:
https://pmc.ncbi.nlm.nih.gov/articles/PMC6430195/
9. Yusuf A, Okafor I, Olubodun T, Onigbogi O. Breast cancer knowledge and screening practices among
undergraduates in a Nigerian tertiary institution, Southwest Region. Afr Health Sci [Internet]. 2022 Dec
[cited 2025 Oct 3];22(4):16–30. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC10117451/
10. Duguma AA, Nguse TM, Dellie ST, Tadesse DA. Level of Awareness of Mammography among Breast
Cancer Patients Attending Follow-up at a Tertiary Hospital, Addis Ababa, Ethiopia. Ethiop J Health Sci
[Internet]. 2022 Oct [cited 2025 Oct 3];32(Spec Iss 1):53–60. Available from:
https://pmc.ncbi.nlm.nih.gov/articles/PMC9624100/
11. Abugu LI, Nwagu EN, Okeke AI, Odo AN. Knowledge of breast cancer, willingness and barriers to
mammography screening among rural women in Enugu State, Nigeria. Afr Health Sci [Internet]. 2023 Sep
[cited 2025 Oct 3];23(3):280–90. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC10862622/
12. Innocent DC, Agwu UF, Uzowuihe PN, Ezejindu CN, Innocent RC, Uwaezuoke AC. Knowledge and
Practice of Breast Cancer Screening among Women in Enugu South, Nigeria. Global Journal of Medical
Research [Internet]. 2023 Feb 6 [cited 2025 Oct 3];23(F1):11–26. Available from:
https://medicalresearchjournal.org/index.php/GJMR/article/view/102270
13. Abuidris DO, Elsheikh A, Ali M, Musa H, Elgaili E, Ahmed AO, et al. Breast-cancer screening with trained
volunteers in a rural area of Sudan: a pilot study. Lancet Oncol. 2013 Apr;14(4):363–70.
14. Nelson NP, Easterbrook PJ, McMahon BJ. Epidemiology of Hepatitis B Virus Infection and Impact of
Vaccination on Disease. Clin Liver Dis [Internet]. 2016 Nov [cited 2025 Jul 11];20(4):607–28. Available
from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5582972/
15. Adeloye D, Sowunmi OY, Jacobs W, David RA, Adeosun AA, Amuta AO, et al. Estimating the incidence of
breast cancer in Africa: a systematic review and meta-analysis. J Glob Health. 2018 Jun;8(1):010419.
16. Thomas DB, Gao DL, Ray RM, Wang WW, Allison CJ, Chen FL, et al. Randomized trial of breast self-
examination in Shanghai: final results. J Natl Cancer Inst. 2002 Oct 2;94(19):1445–57.
17. Ngan TT, Nguyen NTQ, Van Minh H, Donnelly M, O’Neill C. Effectiveness of clinical breast examination
as a “stand-alonescreening modality: an overview of systematic reviews. BMC Cancer. 2020 Nov
9;20(1):1070.
18. Opoku SY, Benwell M, Yarney J. Knowledge, attitudes, beliefs, behaviour and breast cancer screening
practices in Ghana, West Africa. Pan Afr Med J [Internet]. 2012 Feb 17 [cited 2025 Oct 3];11:28. Available
from: https://pmc.ncbi.nlm.nih.gov/articles/PMC3325066/